Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kevin D. McCormick is active.

Publication


Featured researches published by Kevin D. McCormick.


Bioorganic & Medicinal Chemistry Letters | 2011

Steroidal C-21 mercapto derivatives as dissociated steroids: Discovery of an inhaled dissociated steroid

Purakkattle Biju; Kevin D. McCormick; Robert Aslanian; Michael Berlin; Daniel Solomon; Richard W. Chapman; Robbie McLeod; Daniel Prelusky; Stephen Eckel; George Kelly; Michelle Natiello; Aileen House; Xiomara Fernandez; Rema Bitar; Jonathan Phillips; John C. Anthes

A series of C-21 mercapto derivatives of hydrocortisone have been synthesized and evaluated in cell based transrepression and transactivation assays. The benzothiazole derivative, compound 6 not only showed a dissociated profile in vitro functional assays but also a pharmacological profile in a Brown-Norway rat therapeutic index model of asthma that dissociated side effects (thymolysis) while maintaining efficacy against pulmonary inflammation and lung function.


Bioorganic & Medicinal Chemistry Letters | 2013

Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.

Manuel de Lera Ruiz; Junying Zheng; Michael Berlin; Kevin D. McCormick; Robert Aslanian; Robert West; Joyce Hwa; Jean Lachowicz; Margaret van Heek

A novel series of non-imidazole bicyclic and tricyclic histamine H3 receptor antagonists has been discovered. Compound 17 was identified as a centrally penetrant molecule with high receptor occupancy which demonstrates robust oral activity in rodent models of obesity. In addition compound 17 possesses clean CYP and hERG profiles and shows no behavioral changes in the Irwin test.


Bioorganic & Medicinal Chemistry Letters | 2010

Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.

Michael Berlin; Yoon Joo Lee; Christopher W. Boyce; Yi Wang; Robert Aslanian; Kevin D. McCormick; Steve Sorota; Shirley M. Williams; Robert E. West; Walter A. Korfmacher

Structural features of the substituted 4-piperidinyl urea analogs 1, responsible for the H3 antagonist activity, have been identified. Structure-activity relationship of the H3 receptor affinity, hERG ion channel inhibitory activity and their separation is described. Preliminary pharmacokinetic evaluation of the compounds of the series is addressed.


Bioorganic & Medicinal Chemistry Letters | 2014

Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties.

Dong Xiao; Xiaohong Zhu; Younong Yu; Ning Shao; Jie Wu; Kevin D. McCormick; Pawan Dhondi; Jun Qin; Robert Mazzola; Haiqun Tang; Ashwin U. Rao; Phieng Siliphaivanh; Hongchen Qiu; Xiaoxin Yang; Maria A. Rivelli; Charles G. Garlisi; Steve Eckel; Gitali Mukhopadhyay; Craig Correll; Diane Rindgen; Robert Aslanian; Anandan Palani

Isoxazoles are frequently used amide isosteres, as shown in the context of discovery of CRTh2 antagonists from amide 1 to isoxazole 2. However, persistent agonism and poor solubility in isoxazole series presented challenges to its further development. Based on the concept of quality by design (QbD), 5,5-disubstituted isoxazolines 3 were introduced. The chirality at 5 position of isoxazolines controlled the switch between two modes of actions, which led to a novel series of pure antagonists. This non-planar motif also conferred a change of shape of these molecules, which avoided flat structures and improved their physical properties.


Bioorganic & Medicinal Chemistry Letters | 2013

Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.

Qingbei Zeng; Stuart B. Rosenblum; Zhaoxia Yang; Yueheng Jiang; Kevin D. McCormick; Robert Aslanian; Luli Duguma; Joseph A. Kozlowski; Neng-Yang Shih; John A. Hey; Robert West; Walter A. Korfmacher; Michael Berlin; Christopher W. Boyce

A novel series of benzimidazolone-containing histamine H3-receptor antagonists were prepared and their structure-activity relationship was explored. These benzimidazolone analogs demonstrate potent H3-receptor binding affinities, no P450 enzyme inhibition, and strong H3 functional activity. Compound 1o exhibits the best overall profile with H3Ki=0.95nM and rat AUC=12.9μMh.


Bioorganic & Medicinal Chemistry Letters | 2012

Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).

Purakkattle Biju; Kevin D. McCormick; Robert Aslanian; Michael Berlin; Daniel Solomon; Hongwu Wang; Yoon Joo Lee; Rema Bitar; Daniel Prelusky; Robbie McLeod; Yanlin Jia; Xiomora Fernandez; Stephen Eckel; Aileen House; Gissela Lieber; Johanna Jimenez; George Kelly; Richard W. Chapman; Jonathan Phillips; John C. Anthes

The prednisolone C-21 heteroaryl thioethers have been synthesized and evaluated in cell based transrepression and transactivation assays. Most of the compounds demonstrated weak transactivational activity in both human and rat tyrosineaminotransferase functional assay while keeping potent anti-inflammatory activity. The benzimidazole thioether 7 exhibited comparable anti-inflammatory activity and improved safety profile compared to the classical oral steroid prednisolone.


American Journal of Rhinology & Allergy | 2013

Role of α2-adrenoceptors in electrical field stimulation-induced contraction of pig nasal mucosa and pharmacologic characterization of a novel α2C-adrenoceptor agonist.

Michel R. Corboz; Maria A. Rivelli; Himanshu Shah; Christopher W. Boyce; Kevin D. McCormick; Richard W. Chapman; John C. Hunter

Background Blood vessels of the nasal mucosa are richly innervated by sympathetic nerves and neural mechanism is of great interest in upper respiratory tract disorders. This study was designed to determine the role of α2-adrenoceptors and, more specifically, α2C-adrenoceptors, on neurogenic sympathetic vasoconstrictor responses in pig nasal mucosa, and to define the pharmacologic profile of a novel selective α2C-adrenoreceptor agonist. Methods Electrical field stimulation (EFS) was applied to nasal mucosa strips placed in an organ bath and attached to force displacement transducers for continuous recording of isometric tension. The affinity and functional activity of compound B for α2C-adrenoceptors were determined by binding analysis and the ability of compound B to stimulate [35S]GTPγS binding to the receptors. Compound B was also tested in a postjunctional α2C-adrenoreceptor bioassay. Results EFS-induced contractions were partly blocked by the α2-adrenoreceptor antagonist yohimbine (41.1%) and the α2C-adrenoreceptor antagonist JP-1302 had no effect. The α2-adrenoreceptor agonist clonidine, but not compound B, exerted a significant blockade (70.6%). Compound B had high affinity (Ki = 18 nM), produced potent agonist (EC50 = 279 nM) and good efficacy (Emax = 73%) responses at the α2C-adrenoceptors, and displayed good functional agonist potency in the human saphenous vein α2C-adrenoreceptor bioassay (pD2 = 6.2). Conclusion (1) Neurogenic vasomotor contractility is largely regulated through an α-adrenergic mechanism; (2) pig nasal mucosa possesses post- and prejunctional α2-adrenoceptors; (3) the α2C-adrenoreceptor subtype does not seem to be involved; and (4) compound B is a novel, highly selective, and potent α2C-adrenoreceptor agonist.


Bioorganic & Medicinal Chemistry Letters | 2012

Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).

Purakkattle Biju; Hongwu Wang; John C. Anthes; Kevin D. McCormick; Robert Aslanian; Michael Berlin; Rema Bitar; Yeon-Hee Lim; Yoon Joo Lee; Daniel Prelusky; Robbie McLeod; Yanlin Jia; Xiomora Fernandez; Gissela Lieber; Johanna Jimenez; Steve Eckel; Aileen House; Richard W. Chapman; Jonathan Phillips

The introduction of A ring pyrazole modification to the hydrocortisone C-21 heteroaryl thioethers generated compounds with excellent transrepression potency (IL-8 inhibition) compared to their hydrocortisone analogs. However, the transcriptional transactivation activity of these compounds were considerably higher than the corresponding hydrocortisone analogs. Among all the compounds evaluated, a quinoxaline thioether modification demonstrated the best overall in vitro separation.


Archive | 2011

Quinazolinone-type compounds as crth2 antagonists

Robert Aslanian; Christopher W. Boyce; Robert Mazzola; Brian A. McKittrick; Kevin D. McCormick; Anandan Palani; Jun Qin; Haiqun Tang; Dong Xiao; Younong Yu; John P. Caldwell; Elizabeth Helen Kelley; Hongjun Zhang; Phieng Siliphaivanh; Rachel N. Maccoss; Joey L. Methot; Jolicia Polivina Gauuan; Qin Jiang; Andrew J. Leyhane; Purakkattle Biju; Li Dong; Xianhai Huang; Ning Shao; Wei Zhou; Pawan Dhondi; Ashwin U. Rao


Archive | 2008

Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists

Junying Zheng; Kevin D. McCormick; Jianhua Chao; Christopher W. Boyce; Robert Aslanian; Younong Yu

Collaboration


Dive into the Kevin D. McCormick's collaboration.

Researchain Logo
Decentralizing Knowledge